PUBLISHER: Value Market Research | PRODUCT CODE: 1977803
PUBLISHER: Value Market Research | PRODUCT CODE: 1977803
Global Extracorporeal CO2 Removal Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034
The Extracorporeal CO2 Removal Devices Market size is expected to reach USD 202.84 Million in 2034 from USD 102.23 Million (2025) growing at a CAGR of 7.91% during 2026-2034.
The global extracorporeal CO2 removal devices market is expanding due to the rising incidence of respiratory disorders such as COPD and acute respiratory distress syndrome. These devices assist in removing carbon dioxide from the blood, supporting patients with severe respiratory failure. Increasing ICU admissions and demand for advanced life-support technologies are contributing significantly to market growth.
Technological advancements in membrane oxygenation systems and compact portable devices are key drivers. Healthcare facilities are increasingly adopting advanced respiratory support systems to improve patient outcomes. Growing awareness among clinicians and rising prevalence of smoking-related lung diseases further support market expansion. Investments in critical care infrastructure are also playing an important role.
Looking ahead, ongoing clinical research and product innovation will drive future growth. Expanding healthcare facilities in developing regions and increasing focus on non-invasive respiratory management will create new opportunities. As respiratory disorders continue to rise globally, the extracorporeal CO2 removal devices market is expected to witness steady and sustainable growth.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product
- Extracorporeal CO2 Machines
- Disposables
- Others
By Application
- Acute respiratory distress syndrome (ARDS)
- Chronic obstructive pulmonary disease (COPD)
- Bridge to lung transplant
- Others
By Access
- Venovenous
- Arteriovenous
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Others
COMPANIES PROFILED
- Medtronic, Getinge AB, Xenios AG, ALung Technologies Inc, Estor SPA, Medica SPA, Aferetica Srl, Baxter, XCOR Therapeutics, Hemovent GmbH, Abiomed Inc
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Extracorporeal CO2 Machines Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Disposables Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Acute respiratory distress syndrome (ARDS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Chronic obstructive pulmonary disease (COPD) Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Bridge to lung transplant Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET: BY ACCESS 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Access
- 6.2. Venovenous Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Arteriovenous Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET: BY END-USE 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End-use
- 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET: BY REGION 2022-2034(USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Product
- 8.2.2 By Application
- 8.2.3 By Access
- 8.2.4 By End-use
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Product
- 8.3.2 By Application
- 8.3.3 By Access
- 8.3.4 By End-use
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Product
- 8.4.2 By Application
- 8.4.3 By Access
- 8.4.4 By End-use
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Product
- 8.5.2 By Application
- 8.5.3 By Access
- 8.5.4 By End-use
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Product
- 8.6.2 By Application
- 8.6.3 By Access
- 8.6.4 By End-use
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Medtronic
- 10.2.2 Getinge AB
- 10.2.3 Xenios AG
- 10.2.4 ALung Technologies Inc
- 10.2.5 Estor S.P.A
- 10.2.6 Medica S.P.A
- 10.2.7 Aferetica Srl
- 10.2.8 Baxter
- 10.2.9 X-COR Therapeutics
- 10.2.10 Hemovent GmbH
- 10.2.11 Abiomed Inc
